Oncologix Tech Inc (OCLG) financial statements (2022 and earlier)

Company profile

Business Address P.O. BOX 8832
KENTWOOD, MI 49518-8832
State of Incorp. NV
Fiscal Year End August 31
SIC 3841 - Surgical and Medical Instruments and Apparatus (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in thousands)

8/31/2014
8/31/2013
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments1839
Cash and cash equivalents1839
Receivables(9)(3)
Inventory, net of allowances, customer advances and progress billings3131
Inventory3131
Prepaid expense3 
Other undisclosed current assets232150
Total current assets:275218
Noncurrent Assets
Property, plant and equipment4079
Intangible assets, net (including goodwill)1,6841,605
Goodwill1,7821,696
Intangible assets, net (excluding goodwill)(98)(92)
Other undisclosed noncurrent assets137133
Total noncurrent assets:1,8611,816
TOTAL ASSETS:2,1352,034
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities, including:733896
Other undisclosed accounts payable and accrued liabilities733896
Debt83138
Due to related parties666
Other undisclosed current liabilities1,583483
Total current liabilities:2,4051,583
Noncurrent Liabilities
Other undisclosed noncurrent liabilities396812
Total noncurrent liabilities:396812
Total liabilities:2,8002,395
Stockholders' equity
Stockholders' equity attributable to parent, including:(665)(361)
Common stock13575
Additional paid in capital47,56658,560
Accumulated deficit(48,370)(58,992)
Other undisclosed stockholders' equity attributable to parent5(3)
Stockholders' equity attributable to noncontrolling interest (3)
Other undisclosed stockholders' equity 3
Total stockholders' equity:(665)(361)
Other undisclosed liabilities and equity 0
TOTAL LIABILITIES AND EQUITY:2,1352,034

Income statement (P&L) ($ in thousands)

8/31/2014
8/31/2013
Revenues3,677244
Cost of revenue(3,063)(196)
Gross profit:61449
Operating expenses(1,186)(335)
Other operating expense, net
(Other Expenses)
(836)(367)
Other undisclosed operating income836367
Operating loss:(572)(287)
Nonoperating income97 
Investment income, nonoperating96 
Debt instrument, convertible, beneficial conversion feature140 
Other nonoperating expense(139) 
Interest and debt expense80634
Income (loss) from continuing operations before income taxes:330(252)
Other undisclosed loss from continuing operations(902) 
Net loss:(572)(252)
Other undisclosed net loss attributable to parent(740)(401)
Net loss attributable to parent:(1,312)(653)
Other undisclosed net income available to common stockholders, basic 0
Net loss available to common stockholders, diluted:(1,312)(653)

Comprehensive Income ($ in thousands)

8/31/2014
8/31/2013
Net loss:(572)(252)
Comprehensive loss, net of tax, attributable to parent:(572)(252)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: